Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Cash & Equivalents: 2011-2025

Historic Cash & Equivalents for Mesa Laboratories (MLAB) over the last 15 years, with Mar 2025 value amounting to $27.3 million.

  • Mesa Laboratories' Cash & Equivalents fell 16.09% to $20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year decrease of 16.09%. This contributed to the annual value of $27.3 million for FY2025, which is 3.17% down from last year.
  • Mesa Laboratories' Cash & Equivalents amounted to $27.3 million in FY2025, which was down 3.17% from $28.2 million recorded in FY2024.
  • Over the past 5 years, Mesa Laboratories' Cash & Equivalents peaked at $263.9 million during FY2021, and registered a low of $27.3 million during FY2025.
  • In the last 3 years, Mesa Laboratories' Cash & Equivalents had a median value of $28.2 million in 2024 and averaged $29.5 million.
  • As far as peak fluctuations go, Mesa Laboratories' Cash & Equivalents spiked by 224.24% in 2021, and later crashed by 81.30% in 2022.
  • Yearly analysis of 5 years shows Mesa Laboratories' Cash & Equivalents stood at $263.9 million in 2021, then tumbled by 81.30% to $49.3 million in 2022, then tumbled by 33.31% to $32.9 million in 2023, then fell by 14.27% to $28.2 million in 2024, then fell by 3.17% to $27.3 million in 2025.